We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 405.00
Bid: 400.00
Ask: 410.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.50%)
Open: 405.00
High: 405.00
Low: 405.00
Prev. Close: 405.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19 Update

9 Apr 2020 07:00

RNS Number : 2807J
Avingtrans PLC
09 April 2020
 

09 April 2020

Avingtrans plc

("Avingtrans" or the "Group")

Covid-19 Update

Avingtrans PLC (AIM: AVG), the international engineering group which designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, nuclear, defence and medical sectors, today announces an update on its current trading, in response to the impact of Covid-19.

Avingtrans is an international, diversified engineering group, with a strong balance sheet. Our presence in multiple market sectors and the resilience and strength of covenant of many of our customers - including various national governments or their agents - means that many parts of the Group are able to continue to operate at close to normal levels.

As reported in its trading update on 23 January 2020, the Group's order book and prospect pipeline remains robust. However, we are prudently taking immediate measures, in response to the unprecedented conditions affecting its markets, clients and businesses, to reduce its costs and protect its longer-term position, in order to mitigate the effects of near-term disruption.

We have acted decisively to:

· Protect the health and wellbeing of our employees and other stakeholders

· Reduce near-term business costs by making appropriate use of UK and US government stimulus programmes, to maintain employment and capability.

· Conserve cash and liquidity, including the deferral of expected non-critical capex spend.

· Reconfigure our activities to support specific customers, at their request, in the critical national, or international interest

 

Protecting our employees

We are taking all necessary steps to ensure the health and well-being of our employees, clients and suppliers. Appropriate health protocols are in place across all our operations and we have transitioned swiftly to remote working where practical, to minimise business disruption. Approximately 30% of our staff are now working from home.

Business activity continues at most of our sites, with some 45% of our people still able to work safely in our factories. Specifically, we have been requested by certain UK, European and US customers to maintain production, which we are doing, although this leads to some short-term inefficiencies.

Therefore, 75% of our employees are able to perform their duties "normally". However, business progress is being hampered by supply chain disruptions, travel restrictions and government enforced lockdowns in the UK, USA and India. As a result, 20% of our employees (mainly in the UK) have been furloughed at present and operations at the Group's Crown and Composite Products business units have been temporarily suspended. In addition, our aftermarket business is being disrupted by the inability of our service engineers and contractors to travel to customer sites.

Conversely, some market sectors are relatively unaffected - eg Power and Defence. Our Chinese units, in the first region to be severely impacted by the pandemic, are now back to normal levels of operation, with the majority of lost output expected to be recovered by year end.

The remaining 5% of our people are self-isolating at present, either due to experiencing virus symptoms themselves, or having family members who are affected. 

Reducing Costs

Actions taken to reduce costs include:

· Cancelling all upcoming executive annual bonuses and pay increases.

· Reducing the salaries of the Board by 20% from 1 May 2020.

· Salaries of senior management and other employees are being kept under review, as the situation evolves.

· Furloughing 20% of staff, due to reduced activity levels in certain markets and aftermarket field service - notably oil and gas and construction.

 

Conserving Cash

Avingtrans has a modest level of debt and secured facilities with our banks. The Group's net debt position has not moved materially since our interim results were announced in February. However, we must maintain our strong balance sheet and liquidity, position. As at 31 March 2020, the Group had headroom in its facilities of over £8m. The Group has strong, long-term relationships with its banks, who have indicated their on-going support.

Nevertheless, due to the current economic uncertainty, the Board believes it is prudent to take steps to conserve cash, including:

· Utilising government stimulus programmes where available, to support ongoing employment costs in the short term and so to avoid redundancies and maintain capability

· Deferring non-critical capital expenditure for six months, including the Booth building extension

· With the agreement of our Banking partners, taking a capital repayment holiday for three months

· Continuing to seek on time stage payments from key customers to support working capital

 

Current Trading and Outlook

Despite the widespread disruption caused by the pandemic, due to our mitigation actions above, we believe that the year ending 31 May 2020 ("FY20") will be broadly in line with previous management expectations for revenue and profit and our net debt is expected to be no greater than previous guidance.

Given the unprecedented uncertainly around the impact of COVID-19 however, it is not yet possible to assess with certainty the impact this will have on the Group's financial performance for the next financial year. As such, the Group is withdrawing its previous guidance for the year ending 30 May 2021 (FY21).

Due to its diversity and well-proven "PIE" model, the Group is resilient - and in a better position than most to weather the current storm. We may well find ourselves in a strong position to capitalise on the new world order which emerges, as the crisis passes.

Dividend

Notwithstanding the generally robust trading position and the Group's strong balance sheet, the macro economic environment is one of heightened uncertainty. After due consideration, the Board has decided to cancel the interim dividend for the 6 months ended 30 November 2019. The Board recognises the importance of dividends to shareholders and, as such, it intends to consider the appropriateness, quantum and timing of a dividend payment relating to the financial year ended 30 May 2020 when it has a clearer view of the effects of COVID-19 on the Group's business.

Commenting on today's announcement, Steve McQuillan, Chief Executive Officer, said:

"We are all experiencing an unprecedented situation. Our top priority is the health and well-being of our people, clients and suppliers, and ensuring that we take the decisive actions necessary to protect the Group long-term. Both myself and the Board wish to express our thanks to all our employees for their flexibility and resilience during this crisis, which has allowed Avingtrans to continue operating effectively and provide essential support to our clients during this extraordinary period.

Our business model is robust, with strong competitive positions in our markets and differentiated value propositions, which are appreciated by our customers. Indeed, the Group has been designated a critical supplier by government departments in the UK and USA, meaning that Avingtrans is playing an important role in responding to the COVID-19 crisis. However, very few businesses are immune to the current turmoil, so we have taken decisive action in response to the pandemic to reduce costs, bolster our competitiveness and preserve our strong balance sheet". 

This announcement contains inside information.

Enquiries:

Avingtrans plc

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

0135 469 2391

N+1 Singer (Nominated Adviser)Shaun DobsonLauren KettleAlex Bond

 

020 7496 3000

Newgate (Financial PR)Adam LloydTom Carnegie

020 7653 9850

 

 

About Avingtrans plc:

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.

 

Business units

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Lapeer, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above.

 

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Peter Brotherhood - Peterborough, UK

Specialises in the design, manufacture and servicing of performance-critical steam turbines, turbo gen-sets, compressors, gear boxes and combined heat and power systems.

 

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

Crown International Ltd - Portishead, UK

Designs and manufactures market-leading pole and support systems for roadside signage and safety cameras, rail track signalling and gantries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAKLPELDEEFA
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.